Conference Abstract
 
Navigation
Conference Abstracts Index

Abstracts - 2006 London

Abstracts - 2005 Zurich

Abstracts - 2004 Berlin

Abstracts - 2003 Barcelona

Abstracts - 2002 Brussels

Abstracts - 2001 Tokyo

Abstracts - 2000 Marburg

       

14.    Topical administration of cyanocobalamin (vitamin B12) showed suppression of potassium channel inhibitor (tolbutamide) and induction of murine hair anagen phase & synergistic effect with minoxidil. 
Nok-Hyun Park, Skin Research Team, Amore Pacific Corporation R&D Center, South Korea.

Vitamin B12 is well known to be important for growth, cell reproduction, blood formation, and protein & tissue synthesis. Cyanocobalamin and hydroxocobalamin acetate are used to treat pernicious anemia, nutritional vitamin B12 deficiency, malabsorption of vitamin B12, and other cases of vitamin B12 deficiency.
We investigated the active effect of vitaminB12 on NIH3T3 fibroblast in ATP-sensitive potassium channel-dependent fashion and on murine anagen indution. The in vitro effects of established potassium channel openers (minoxidil) and inhibitors (tolbutamide), plus vitamin B12 were indirectly assessed on NIH3T3 fibroblast in the absence of aminoglycoside antibiotics & phenol red, and 5% fetal bovine serum-supplemented medium. Tolbutamide inhibited 28% proliferation of NH3T3 fibroblast at 2.5mM concentration as reported previously. When minoxidil & cyanocobalamin was treated to the fibroblast with 2.5mM tolbutamide, growth inhibition of NIH3T3 fibroblast was suppressed 51.49% by 100uM minoxidil 38.39% by 1uM cyanocobalamin, respectively. Two topical preparations of single dose of minoxidil (1%) and cyanocobalamin (0.03%) were topically administered with vehicle (ethanol/ propylene glycol/ water= 3/ 2/ 5) on clipped dorsal area of female telogen phase C57bl/6. The grown hair weights of topical 1% minoxidil preparation (113.14¡¾11.02mg, P<0.001) and 0.03% cyanocobalamin (59.56¡¾13.88mg, P<0.05) increased significantly than that of vehicle (18.47¡¾4.68mg). When topically administered in mixed preparations (0.5% minoxidil and 0.03% cyanocobalamin), the more grown hair weight (87.00¡¾8.39mg, P<0.03 t-test with 0.05% minoxidil) by mixed preparation was observed compared to those of single 0.5% minoxidil preparation (44.33¡¾14.96mg) & of vehicle preparation (22.13¡¾13.86mg). Topical cyanocobalamin was applied to atopic dermatitis and psoriasis in previous study; our new topical trial of vitamin B12 will be helpful treatment for alopecia as a single dose or coadministraition with minoxidil though the precise mechanism was not elucidated.